This site requires JavaScript to be enabled to work properly. Please modify your settings or use a different browser to continue


You are now leaving GSK’s website

This link will take you to a non-GSK website. GSK does not recommend, endorse or accept liability for sites controlled by third-parties.


Go back


fluticasone furoate/vilanterol

RelvarTM ElliptaTM (fluticasone furoate/vilanterol) is an inhaled corticosteroid/long acting beta 2 agonist (ICS/LABA) combination for asthma patients (≥12 years) uncontrolled on ICS alone and ‘as needed’ SABA.

Know more about Relvar

View our products

View our products

Find comprehensive information on our products including resources for patients.



Keppra is available in different concentration and forms to match different patients profiles and needs.

Know more about Keppra

Expert perspectives

Expert perspectives

By sharing our knowledge, we hope we can ultimately improve the lives of patients.  To do that we’ve developed the GSK Portal so healthcare professionals can have easy access to all our resources, tools, advice, opinion and news.

All mentioned products are registered medicine or vaccine for GSK Saudi. This website contains promotional content. For adverse event reporting to one of GSK medicines / vaccines, please contact our representative, fill the form on this website or contact GSK Head office on the address below: ©2018 GlaxoSmithKline, All rights reserved. GlaxoSmithKline Saudi Arabia, P.O. Box 55850, Jeddah 21544, Saudi Arabia. Tel: (012) 6536666 Fax: (012) 6536660